Roger Ove

Prof. Roger Ove

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Advances in Biological Regulation
Verified
Journal Article
Closed access
WCWilliam H. Chappell
William H. Chappell
SCSaverio Candido
Saverio Candido
SAStephen L. Abrams
Stephen L. Abrams
SRSuzanne Russo
Suzanne Russo
RORoger Ove
Roger Ove
JMJames A. McCubrey
James A. McCubrey

1 February 2012 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
RORoger Ove
Roger Ove
RCRonaldo Cavalieri
Ronaldo Cavalieri
DNDarin Cmd Noble
Darin Cmd Noble
SRSuzanne M. Russo
Suzanne M. Russo
Purpose An understanding of the setup variation of the low neck in relation to the upper neck is necessary to define appropriate planning margins, while treating the full neck with intensity-modulated radiotherapy (IMRT) technique. Materials and Methods The setup of 20 sequential head and neck cancer patients was studied. Daily position verification was performed with a computed tomography (CT) on rails. An upper neck point was defined as the anterior-most portion of the cervical spine on the lowest CT cut on which both styloid processes are visible. A low neck point was defined as the anterior-most portion of the cervical spine on the lowest CT cut on which the thyroid gland was visible bilaterally. This procedure was carried out on the planning CT and on each daily treatment CT. The variation of the low neck was analyzed, assuming perfect alignment of the upper neck anatomy. Results Daily treatment CT of upper neck anterior cervical spine points were normalized to the planning CT. Relative to this coordinate system, the low neck cervical spine point was displaced an average of 3.08 mm anteriorly, ±0.17 mm. There was no systematic lateral or craniocaudal displacement. Random setup errors resulted in low neck standard deviations of 3.9 mm (anteroposterior), 3.3 mm (lateral), and 2.6 mm (craniocaudal). Conclusions Position variation in the low neck varied in excess of the planning margins. There was a systematic anterior displacement. Random setup error was greater than expected. The results suggest that the neck volumes located distant from the region of fusion should be drawn with larger planning margins.

20 April 2016 in Future Oncology
Verified
Journal Article
Closed access
RORoger Ove
Roger Ove
LNLisle M Nabell
Lisle M Nabell
Integration and optimization of active systemic agents and radiosensitizers into the therapeutic regimen for head and neck cancer remains a topic of active investigation. Recent trials have not consistently supported the use of induction chemotherapy. There are several clinical scenarios in which there is a strong rationale for induction chemotherapy, such as larynx preservation, unfavorable sites and bulky locally advanced disease. The increasing prevalence of HPV-positive malignancies, impacts both interpretation of clinical research and the design of future trials. In the broad spectrum of this disease the prognosis is often dismal, with substantial room for improvement over current therapy. In the face of conflicting clinical data, we address the question of whether there remains a role for induction chemotherapy.

9 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
RARishabh Agrawal
Rishabh Agrawal
ADAsoke Kumar Dey
Asoke Kumar Dey
SDSujay Datta
Sujay Datta
ANAna Nassar
Ana Nassar
WGWilliam Grubb
William Grubb
TPTarun Podder
Tarun Podder
Background: In this study, the utilization rates and survival outcomes of different radiotherapy techniques are compared in prostate cancer (PCa) patients stratified by risk group. Methods: We analyzed an extensive data set of N0, M0, non-surgical PCa patients diagnosed between 2004 and 2015 from the National Cancer Database (NCDB). Patients were grouped into six categories based on RT modality: an intensity-modulated radiation therapy (IMRT) group with brachytherapy (BT) boost, IMRT with/without IMRT boost, proton therapy, stereotactic body radiation therapy (SBRT), low-dose-rate brachytherapy (BT LDR), and high-dose-rate brachytherapy (BT HDR). Patients were also stratified by the National Comprehensive Cancer Network (NCCN) guidelines: low-risk (clinical stage T1–T2a, Gleason Score (GS) ≤ 6, and Prostate-Specific Antigen (PSA) < 10), intermediate-risk (clinical stage T2b or T2c, GS of 7, or PSA of 10–20), and high-risk (clinical stage T3–T4, or GS of 8–10, or PSA > 20). Overall survival (OS) probability was determined using a Kaplan–Meier estimator. Univariate and multivariate analyses were performed by risk group for the six treatment modalities. Results: The most utilized treatment modality for all PCa patients was IMRT (53.1%). Over the years, a steady increase in SBRT utilization was observed, whereas BT HDR usage declined. IMRT-treated patient groups exhibited relatively lower survival probability in all risk categories. A slightly better survival probability was observed for the proton therapy group. Hormonal therapy was used for a large number of patients in all risk groups. Conclusion: This study revealed that IMRT was the most common treatment modality for PCa patients. Brachytherapy, SBRT, and IMRT+BT exhibited similar survival rates, whereas proton showed slightly better overall survival across the three risk groups. However, analysis of the demographics indicates that these differences are at least in part due to selection bias.

1 September 2004 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
PDF file
SYS. Ye
S. Ye
RORoger Ove
Roger Ove
SSS. Shen
S. Shen
SRS. Russo
S. Russo
IBI.A. Brezovich
I.A. Brezovich
Balloon catheter brachytherapy is becoming widely used in the treatment of early-stage breast cancer, due to its ease of use, short learning curve, and requirement of only one interstitial catheter through the breast. However, recent studies have shown that the dosimetry is not as simple as previously thought, due to iodine-containing radiographic contrast medium in the balloon, the lack of scatter medium, as well as source anisotropy.

20 February 2015 in Journal of Radiation Oncology
Verified
Journal Article
Closed access
PDF file
RORoger Ove
Roger Ove
CPColbert A. Parker
Colbert A. Parker
MCMadhu B. Chilukuri
Madhu B. Chilukuri
SRSuzanne M. Russo
Suzanne M. Russo